Atlas Trials

A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities

Clinical trial NCT06277934 · COMPLETED

Trial details

NCT number
NCT06277934
Sponsor
Regor Pharmaceuticals Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Obesity
Start date
2024-03-08
Primary completion
2024-08-13
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.